SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
09-Jun-22 8:02 PM View: | Hernandez Joseph Director | Clarus Therapeutics Holding... (BLUWU) | 07-Jun-22 | Grant | 1,922 | -- | -- | < 1% 1.31M to 1.31M | |
09-Jun-22 8:06 PM View: | Prygocki Mark A Sr Director | Clarus Therapeutics Holding... (BLUWU) | 07-Jun-22 | Grant | 1,922 | -- | -- | 50% 3.84K to 5.77K | |
09-Jun-22 8:02 PM View: | Amory John Kenneth Director | Clarus Therapeutics Holding... (BLUWU) | 07-Jun-22 | Grant | 1,922 | -- | -- | 50% 3.84K to 5.77K | |
09-Jun-22 8:00 PM View: | Cermak Elizabeth Director | Clarus Therapeutics Holding... (BLUWU) | 07-Jun-22 | Grant | 1,922 | -- | -- | 50% 3.84K to 5.77K | |
09-Jun-22 8:04 PM View: | Murphy Kimberly M Director | Clarus Therapeutics Holding... (BLUWU) | 07-Jun-22 | Grant | 1,922 | -- | -- | 50% 3.84K to 5.77K | |
27-Apr-22 4:09 PM View: | Hernandez Joseph Director | Clarus Therapeutics Holding... (BLUWU) | 25-Apr-22 | Acquisition (other) | 1,237,500 | -- | -- | 95% 1.31M to 2.54M | |
27-Apr-22 4:09 PM View: | Hernandez Joseph Director | Clarus Therapeutics Holding... (BLUWU) | 25-Apr-22 | Disposition (other) | 65,000 | -- | -- | (3%) 2.54M to 2.48M | |
14-Dec-21 7:00 PM View: | Murphy Kimberly M Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 3,844 | -- | -- | 100% 0 to 3.84K | |
14-Dec-21 7:00 PM View: | Amory John Kenneth Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 3,844 | -- | -- | 100% 0 to 3.84K | |
14-Dec-21 7:00 PM View: | Hernandez Joseph Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 3,844 | -- | -- | < 1% 1.3M to 1.31M | |
14-Dec-21 7:00 PM View: | Cermak Elizabeth Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 3,844 | -- | -- | 100% 0 to 3.84K | |
14-Dec-21 7:00 PM View: | Dudley Robert E. Chief Executive Officer Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 135,000 | -- | -- | 2957% 4.57K to 139.57K | |
14-Dec-21 7:03 PM View: | Prygocki Mark A Sr Director | Clarus Therapeutics Holding... (BLUWU) | 12-Dec-21 | Grant | 3,844 | -- | -- | 100% 0 to 3.84K | |
14-Dec-21 7:00 PM View: | Peterson Richard D Chief Financial Officer | Clarus Therapeutics Holding... (BLUWU) | 11-Dec-21 | Grant | 55,800 | -- | -- | 100% 0 to 55.8K | |
14-Dec-21 7:02 PM View: | Jaeger Frank Chief Commercial Officer | Clarus Therapeutics Holding... (BLUWU) | 11-Dec-21 | Grant | 29,000 | -- | -- | 100% 0 to 29.0K | |
14-Dec-21 7:00 PM View: | Bourne Steven A. Chief Administrative Officer | Clarus Therapeutics Holding... (BLUWU) | 11-Dec-21 | Grant | 29,000 | -- | -- | 2222% 1.3K to 30.3K | |
21-Sep-21 10:00 PM View: | Ffi Fund Ltd 10% Owner | Clarus Therapeutics Holding... (BLUWU) | 17-Sep-21 | Market Sale | 127,360 | $9.20 | $1,171,710.00 | (6%) 2.23M to 2.1M | (12%) |
13-Sep-21 8:28 PM View: | Bourne Steven A. Chief Administrative Officer | Clarus Therapeutics Holding... (BLUWU) | 09-Sep-21 | Grant | 1,305 | -- | -- | 100% 0 to 1.3K | |
04-Oct-21 4:09 PM View: | H.I.G. Ventures - Clarus, LLC 10% Owner | Clarus Therapeutics Holding... (BLUWU) | 09-Sep-21 | Grant Duplicate | 5,692,380 | -- | -- | 100% 0 to 5.69M | |
13-Sep-21 8:31 PM View: | Dudley Robert E. Chief Executive Officer Director | Clarus Therapeutics Holding... (BLUWU) | 09-Sep-21 | Grant | 4,566 | -- | -- | 100% 0 to 4.57K | |
13-Sep-21 8:33 PM View: | Zisson Alex Director 10% Owner | Clarus Therapeutics Holding... (BLUWU) | 09-Sep-21 | Grant | 5,692,380 | -- | -- | 100% 0 to 5.69M |